agena-bioscience-logo
  • Products
  • Applications
  • Customer Success
  • Company
  • Contact
EN - Global CN - 中国

menu

agena-bioscience-logo agena-bioscience-logo Close
  • Home
  • Products
    • System
    • Panels
  • Applications
    • Pharmacogenetics
    • Liquid Biopsy
    • Tumor Profiling
    • SARS-CoV-2 Testing
    • Sample Integrity
    • Specimen Validity
    • Hereditary Genetics
    • Methylation
    • Chimerism
    • Blood Typing
  • Customer Success
  • Services
    • Assays by Agena
    • Insights Reporting Partners
    • Certified Service Providers
  • Resources
    • Videos & Webinars
    • Product Literature
    • Publication Library
    • Articles
  • Support
    • Service Plans
    • Distributors
    • Certified Service Providers
  • Company
    • Careers
    • Press
  • Contact
  • Customer Support Portal
  • Home
  • Products
    • System
    • Panels
  • Applications
    • Pharmacogenetics
    • Liquid Biopsy
    • Tumor Profiling
    • SARS-CoV-2 Testing
    • Sample Integrity
    • Specimen Validity
    • Hereditary Genetics
    • Methylation
    • Chimerism
    • Blood Typing
  • Customer Success
  • Services
    • Assays by Agena
    • Insights Reporting Partners
    • Certified Service Providers
  • Resources
    • Videos & Webinars
    • Product Literature
    • Publication Library
    • Articles
  • Support
    • Service Plans
    • Distributors
    • Certified Service Providers
  • Company
    • Careers
    • Press
    • Seminars & Webinars
  • Contact
  • Customer Support Portal

Phone: (858) 882-2800

Home / Resources / Publication Library / Publication Library Search

Search All publications

  • Limitation of standard pseudoisochromatic plates in identifying colour vision deficiencies when compared with genetic testing
  • BRAF Immunoexpression Can Be Intralesionally Heterogeneous but BRAF V600E Mutation Status Is Intralesionally Homogeneous and Interlesionally Concordant in Melanoma: A Study of 140 Lesions From 98 Patients
  • DBP rs7041 and DHCR7 rs3829251 are Linked to CD4+ Recovery in HIV Patients on Antiretroviral Therapy
  • Clinical performance of the full genotyping Agena MassARRAY HPV assay using SurePath screening samples within the VALGENT4 framework
  • The Relationship between Cadherin Polymorphisms and the Risk of Delayed Encephalopathy after Acute Carbon Monoxide Poisoning in the Chinese Han Population
  • Exome Sequencing with Validations and Expression of p16/CDKN2A Shows no Association with HPV in Oral Cancers
  • Genetic polymorphisms and correlation with treatment induced cardiotoxicity and prognosis in breast cancer patients
  • Coffee consumption and its interaction with the genetic variant AhR rs2066853 in colorectal cancer risk: A case-control study in Korea
  • Pharmacogene Variants Associated with Liver Transplant in a Twelve-Year Clinical Follow-Up
  • Genetic and Clinical Factors Associated with Opioid Response in Chinese Han Patients with Cancer Pain: An Exploratory Cross-Sectional Study
«...34567...102030...»
Company
  • About Us
  • Careers
  • Contact
Resources
  • Video Library
  • ISO Certifications
  • Clinical Approval
  • Patents
    Customer Support
    • Customer Support Portal
    • Support Contacts
Agena Bioscience

4755 Eastgate Mall,
San Diego, CA 92121

p. (858) 882-2800,  f. (858) 882-2727

With exception of the MassARRAY Dx, all other products are For Research Use Only. Not for use in diagnostic procedures.
© 2020-2023 Agena Bioscience, Inc. All rights reserved. Agena Bioscience is a subsidiary of Mesa Labs, Inc.

  • Privacy Policy
  • Website Terms & Conditions
  • Product Terms & Conditions
  • Warranty